Safety and Efficacy of Topical Recombinant Human Thrombin(rhThrombin) for Surgical Hemostasis
Clinical trial NCT04459871 · COMPLETED
Trial details
- NCT number
- NCT04459871
- Sponsor
- Suzhou Zelgen Biopharmaceuticals Co.,Ltd
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-11-11
- Primary completion
- 2021-10-20
- Enrollment
- 348
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.